The time has come for DNA testing of cancer patients to become a routine practice, argues England’s chief medical officer Professopr Dame Sally Davies.
More than 31,000 National Health Service (NHS) patients, including some with cancer, have had their entire genome mapped, though Dame Sally wants this to become a standard procedure not just for oncology patients but also other therapeutic areas including rare diseases and infections.
She makes this recommendation in her annual report entitled 2016: Generation Genome. This discusses the current state of genomic service provision in the NHS in England and explores the potential of genomics to improve health and prevent ill-health.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze